Beyond the virus: Ensuring continuity of care for people with diabetes during COVID-19

Beran, David; Perone, Sigiriya Aebischer; Perolini, Montserrat Castellsague; Chappuis, François; Chopard, Pierre; Haller, Dagmar M.; Bausch, Frédérique Jacquerioz; Maisonneuve, Hubert; Perone, Nicolas; Gastaldi, Giacomo

doi:10.1016/j.pcd.2020.05.014

Cited by 75 publications

(77 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our results are in support of the scientific/clinical opinion that COVID-19 patients with diabetes should be given much attention considering the associated higher risk of mortality in COVID-19 patients with diabetes. The recommendations and special considerations proposed for managing diabetic patients with COVID-19 are available elsewhere [1] , [2] , [3] .…”

Section: Discussionmentioning

confidence: 99%

“…Studies have linked fatal outcomes in COVID-19 to the associated comorbidities. Evidence reported in the Journal of Diabetes and Centers for Disease Control and Prevention (CDC) showed diabetes as the most important comorbidity associated with a 50% higher risk of fatal outcomes in COVID-19 cases with diabetes than their non-diabetic counterparts [1] , [2] , [3] . Considering the global concern for COVID-19 pandemic in the diabetes community, we aim to evaluate the risk of disease severity and mortality in association with diabetes in COVID-19 patients.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Diabetes and COVID-19: A pooled analysis related to disease severity and mortality

Varikasuvu

Dutt

Thangappazham

et al. 2021

Primary Care Diabetes

View full text Add to dashboard Cite

Highlights COVID-19 pandemic in the diabetes community has become a worldwide concern. The association between diabetes and COVID-19 progression was studied by pooled analysis. COVID-19 patients with diabetes have a significantly higher risk of disease severity (OR = 2.20, 95% CI = 1.69–2.86, p < 0.00001). COVID-19 patients with diabetes have a significantly higher mortality outcomes risk (OR = 2.52, 95% CI = 1.93–3.30, p < 0.00001).

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Diabetes and COVID-19: A pooled analysis related to disease severity and mortality

Varikasuvu

Dutt

Thangappazham

et al. 2021

Primary Care Diabetes

View full text Add to dashboard Cite

show abstract

“…Concerning authorities should make sure that no shortage of such devices happens. Regardless of the existence of pandemic, such devices help diabetics for self-monitoring and self-care [ 23 ].…”

Section: Discussionmentioning

confidence: 99%

A cross sectional study reveals severe disruption in glycemic control in people with diabetes during and after lockdown in India

Khader

Jabeen

Namoju

2020

Diabetes & Metabolic Syndrome: Clinical Research & Revi

View full text Add to dashboard Cite

Background and aims: Uncontrolled diabetes has been associated with poorer clinical outcomes in COVID-19. We aimed to evaluate and assess the impact of COVID-19 pandemic on management of diabetes and challenges faced by people with diabetes in India during and after the lockdown phase. Methods: A cross-sectional study based on an online questionnaire survey was designed. The questions collected socio-demographic details, medical and social history, and impact of the pandemic on medical and social life from 1582 participants. Linear regression was employed to evaluate association of different parameters with the change in glycemic levels. Results: The frequency of clinical visits during the COVID-19 pandemic were reduced in 87.28% of participants. 92.45% of participants were able to monitor their blood glucose levels (BGLs) in which 78.42% (49.35%, 20.91%, and 8.16%) participants experienced an increase in BGL (mild, moderate, and severe respectively). Only 47.41% of participants possessed the digital glucometer at home. 69.07% of participants reported a decrease in physical activity while 46.88% reported an increase in food intake. 80.06% of participants were able to buy all medicines and 29.80% were gone for virtual consultations while 87.81% reported that they didn’t have access to healthcare services. Overall, 89.47% participants experienced disruption in therapy. A highly significant correlation (r = 0.89, p = 0.0145) was found between increasing age and reporting of higher BGLs. Conclusion: This study provides a firsthand evidence of major disruption in diabetes care activities during and after the lockdown phase in India and increased risk of poorer clinical outcomes, if infected by SARS-CoV-2.

show abstract

“…Para ello, el primer paso es reorientar el manejo de las ECNT hacia el primer nivel de atención (34) para brindar la atención necesaria y evitar que las personas con diabetes y otras ECNT acudan a los hospitales durante y después de la cuarentena. Ello requiere trabajar en los cuatro pilares de la atención primaria para las personas con diabetes: accesibilidad y primer contacto, longitudinalidad, integralidad y coordinación (35) .…”

Section: Conclusionesunclassified

Los retos del cuidado de las personas con diabetes durante el estado de emergencia nacional por la COVID-19 en Lima, Perú: recomendaciones para la atención primaria

Pesantes

Lazo-Porras

Cárdenas

et al. 2020

Rev Peru Med Exp Salud Publica

View full text Add to dashboard Cite

Las personas con diabetes mellitus tipo 2 infectadas por SARS-CoV-2 tienen mayores riesgos de desarrollar COVID-19 con complicaciones y de morir como consecuencia de ella. La diabetes es una condición crónica en la que se requiere continuidad de cuidados que implican un contacto con los establecimientos de salud, pues deben tener acceso regular a medicamentos, exámenes y citas con personal de salud. Esta continuidad de cuidados se ha visto afectada en el Perú a raíz de la declaratoria del estado de emergencia nacional, producto de la pandemia por la COVID-19 pues muchos establecimientos de salud han suspendido las consultas externas. Este artículo describe algunas estrategias que han desarrollado los diferentes proveedores de salud peruanos en el marco de la pandemia para proveer continuidad del cuidado a las personas con diabetes y finalmente brinda recomendaciones para que reciban los cuidados que necesitan a través del fortalecimiento del primer nivel de atención, como el punto de contacto más cercano con las personas con diabetes.

show abstract

Beyond the virus: Ensuring continuity of care for people with diabetes during COVID-19

Cited by 75 publications

References 5 publications

Diabetes and COVID-19: A pooled analysis related to disease severity and mortality

Diabetes and COVID-19: A pooled analysis related to disease severity and mortality

A cross sectional study reveals severe disruption in glycemic control in people with diabetes during and after lockdown in India

Los retos del cuidado de las personas con diabetes durante el estado de emergencia nacional por la COVID-19 en Lima, Perú: recomendaciones para la atención primaria

Contact Info

Product

Resources

About